Back
XTL Biopharmaceuticals Vs. BioLine Rx Industry Stock Comparison
Sell
44
XTLB
XTL Biopharmaceuticals
Last Price:
2.53
Seasonality Move:
-7.87%
Sell
42
BLRX
BioLine Rx
Last Price:
0.62
Seasonality Move:
-6.69%
Sell
44
XTL Biopharmaceuticals (XTLB)
is a Sell
Is XTL Biopharmaceuticals a Buy, Sell or Hold?
- The current XTL Biopharmaceuticals [XTLB] share price is $2.56. The Score for XTLB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- XTLB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy, Sell or Hold?
- The current BioLine Rx [BLRX] share price is $0.62. The Score for BLRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- BLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XTLB Stock Price Chart
What is XTL Biopharmaceuticals's stock price today?
-
The XTL Biopharmaceuticals share price today is $2.56
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLRX Stock Price Chart
What is BioLine Rx's stock price today?
-
The BioLine Rx share price today is $0.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing selling pressure, which indicates risk of future bearish movement.
XTLB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 48.96 | Sell |
Chaikin Money Flow: | 1319 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.48 - 2.7) | Sell |
Bollinger Bands (100): | (2.34 - 2.76) | Buy |
BLRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 42.66 | Sell |
Chaikin Money Flow: | -144939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.61 - 0.67) | Sell |
Bollinger Bands (100): | (0.6 - 0.76) | Sell |
XTLB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.48 | Buy |
20-day SMA: | 2.58 | Sell |
50-day SMA: | 2.66 | Sell |
200-day SMA: | 2.03 | Buy |
8-day EMA: | 2.52 | Buy |
20-day EMA: | 2.56 | Buy |
50-day EMA: | 2.58 | Sell |
200-day EMA: | 2.17 | Buy |
BLRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.64 | Sell |
20-day SMA: | 0.63 | Sell |
50-day SMA: | 0.7 | Sell |
200-day SMA: | 0.92 | Sell |
8-day EMA: | 0.64 | Sell |
20-day EMA: | 0.65 | Sell |
50-day EMA: | 0.67 | Sell |
200-day EMA: | 0.88 | Sell |
XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioLine Rx Earnings Growth & BLRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.03 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.
XTL Biopharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BioLine Rx Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |